Discover how generic drugs and biosimilars saved the US healthcare system $3.4 trillion over a decade and why they are critical for keeping prescription costs manageable.
Most clinicians don't know the real cost of the drugs they prescribe. This gap leads to unnecessary expenses, non-adherence, and preventable harm. Real-time cost tools are changing that - but only where they're implemented.